Scandmedical Soldk 040 Stock Total Asset
| K41 Stock | 0.83 0.03 3.49% |
SCANDMEDICAL SOLDK 040 fundamentals help investors to digest information that contributes to SCANDMEDICAL SOLDK-040's financial success or failures. It also enables traders to predict the movement of SCANDMEDICAL Stock. The fundamental analysis module provides a way to measure SCANDMEDICAL SOLDK-040's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SCANDMEDICAL SOLDK-040 stock.
SCANDMEDICAL |
SCANDMEDICAL SOLDK 040 Company Total Asset Analysis
SCANDMEDICAL SOLDK-040's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, SCANDMEDICAL SOLDK 040 has a Total Asset of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The total asset for all Germany stocks is 100.0% higher than that of the company.
SCANDMEDICAL Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SCANDMEDICAL SOLDK-040's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SCANDMEDICAL SOLDK-040 could also be used in its relative valuation, which is a method of valuing SCANDMEDICAL SOLDK-040 by comparing valuation metrics of similar companies.SCANDMEDICAL SOLDK is currently under evaluation in total asset category among its peers.
About SCANDMEDICAL SOLDK-040 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SCANDMEDICAL SOLDK 040's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SCANDMEDICAL SOLDK-040 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SCANDMEDICAL SOLDK 040 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in SCANDMEDICAL Stock
SCANDMEDICAL SOLDK-040 financial ratios help investors to determine whether SCANDMEDICAL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SCANDMEDICAL with respect to the benefits of owning SCANDMEDICAL SOLDK-040 security.